Avidan U. Neumann
Impact in
- Virology top 0.02%
- HIV Research and Treatment
- Hepatology top 0.1%
- Hepatitis C virus research
Papers in
- Hepatology 68
- Hepatitis C virus research 66
- Virology 30
- HIV Research and Treatment 30
- Co-authors
- Alan S. PerelsonDavid D. HoMartin MarkowitzJohn M. LeonardWen ChenHarel DahariThomas J. LaydenThelma E. Wiley
- Journals
- Journal of Hepatology (18 papers)Hepatology (9 papers)Journal of Viral Hepatitis (8 papers)Gastroenterology (7 papers)Bulletin of Mathematical Biology (7 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Avidan U. Neumann
146 papers receiving 16.1k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Virology 7.6k
- Hepatology 5.2k
- Infectious Diseases 5.5k
- Immunology 4.1k
- Epidemiology 5.8k
Countries citing papers authored by Avidan U. Neumann
This map shows the geographic impact of Avidan U. Neumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avidan U. Neumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avidan U. Neumann more than expected).
Fields of papers citing papers by Avidan U. Neumann
This network shows the impact of papers produced by Avidan U. Neumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avidan U. Neumann. The network helps show where Avidan U. Neumann may publish in the future.
Co-authors
The 25 scholars most cited alongside Avidan U. Neumann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 13 | |
| 4 | 2022 | 20 | |
| 5 | Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors Hit paper breakdown → | 2020 | 387 |
| 6 | 2018 | 256 | |
| 7 | 2015 | 32 | |
| 8 | 2011 | 122 | |
| 9 | Ip-10 Is Associated With Il28b Variation And Predicts The First Phase Decline Of Hcv Rna And Outcome Of Therapy In Chronic Hepatitis C | 2010 | 2 |
| 10 | 2010 | 7 | |
| 11 | 2010 | 27 | |
| 12 | 2010 | 9 | |
| 13 | 2010 | 60 | |
| 14 | 2008 | 1 | |
| 15 | 2007 | 1 | |
| 16 | 2007 | 3 | |
| 17 | Viral kinetics of HCV genotype 5 in South Africa patients treated with pegylated-interferon-alpha and Ribaviron | 2007 | 1 |
| 18 | 2006 | 190 | |
| 19 | 1998 | 22 | |
| 20 | 1997 | 283 |
About Avidan U. Neumann
Avidan U. Neumann is a scholar working on Hepatology, Virology, Epidemiology, Rheumatology and Immunology, having authored 149 papers that have together received 16.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (66 papers), Hepatitis B Virus Studies (37 papers), Liver Disease Diagnosis and Treatment (37 papers), HIV Research and Treatment (30 papers), Systemic Lupus Erythematosus Research (23 papers), Immune Cell Function and Interaction (18 papers), T-cell and B-cell Immunology (18 papers) and HIV/AIDS drug development and treatment (13 papers). The work is most often cited by research in Virology (7.6k citations), Hepatology (5.2k citations), Infectious Diseases (5.5k citations), Immunology (4.1k citations) and Epidemiology (5.8k citations). Avidan U. Neumann has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Alan S. Perelson, David D. Ho, Martin Markowitz, John M. Leonard, Wen Chen, Harel Dahari, Thomas J. Layden, Thelma E. Wiley, David R. Gretch and Nancy P. Lam. Their work appears in journals such as Journal of Hepatology, Hepatology, Journal of Viral Hepatitis, Gastroenterology and Bulletin of Mathematical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.